Rayzebio Inc (RYZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RYZB | ACLX | ARQT | ||
| Company | Rayzebio Inc | Arcellx Inc | Arcutis Biotherapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 62.49 | 66.04 | 29.34 | ||
| High | 62.50 | 66.79 | 29.55 | ||
| Low | 62.48 | 65.79 | 29.14 | ||
| Latest | 62.49 | 66.00 | 29.45 | ||
| Change | +0.01 | +0.49 | +0.14 | ||
| % Change | +0.02% | +0.75% | +0.48% | ||
| Volume | 282,700 | 289,400 | 383,200 | ||
| 20-Day Average Volume | 318,060 | 1,321,660 | 1,966,645 | ||
| Previous Close | 62.48 | 65.51 | 29.31 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 62.28 | 69.08 | 29.65 | ||
| 20-Day Raw Stochastic | 95.83% | 15.49% | 45.09% | ||
| 20-Day Relative Strength | 86.10 | 37.62 | 58.71 | ||
| Weighted Alpha | N/A | -17.32 | +124.72 | ||
| Today's Opinion | N/A | 40% Sell | 80% Buy | ||
| Previous Opinion | N/A | 40% Sell | 80% Buy | ||
| Last Month's Opinion | N/A | 48% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 02/15/24 | +1.98% since 12/17/25 | +3.92% since 12/17/25 | ||
| Low | 62.42 on 02/16/24 | 63.48 on 12/19/25 | 27.55 on 12/18/25 | ||
| High | 62.51 on 02/22/24 | 66.79 on 12/24/25 | 30.26 on 12/23/25 | ||
| 1-Month | |||||
| %Chg | +0.87% since 01/23/24 | -11.95% since 11/24/25 | -4.26% since 11/24/25 | ||
| Low | 61.86 on 01/24/24 | 63.48 on 12/19/25 | 27.55 on 12/18/25 | ||
| High | 62.51 on 02/22/24 | 79.75 on 12/08/25 | 31.77 on 12/08/25 | ||
| 3-Month | |||||
| %Chg | +167.05% since 11/22/23 | -16.19% since 09/24/25 | +70.23% since 09/24/25 | ||
| Low | 22.14 on 11/27/23 | 63.48 on 12/19/25 | 16.57 on 09/25/25 | ||
| High | 62.51 on 02/22/24 | 94.07 on 10/16/25 | 31.77 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | N/A since 09/15/23 | +4.18% since 06/24/25 | +105.51% since 06/24/25 | ||
| Low | 17.95 on 09/26/23 | 62.70 on 06/25/25 | 13.06 on 07/07/25 | ||
| High | 62.51 on 02/22/24 | 94.07 on 10/16/25 | 31.77 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,744,400 | 3,816,318 | 3,607,389 | ||
| Shares Outstanding, K | 59,920 | 57,823 | 122,492 | ||
| Annual Sales | 0 | 107,940,000 | 196,540,000 | ||
| Annual Net Income | -68,600,000 | -107,350,000 | -140,040,000 | ||
| Last Quarter Sales | 0 | 4,950,000 | 99,220,000 | ||
| Last Quarter Net Income | -18,190,000 | -55,780,000 | 7,410,000 | ||
| 60-Month Beta | N/A | 0.34 | 1.69 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 11/13/23 | -0.99 on 11/05/25 | 0.06 on 10/28/25 | ||
| Latest Earnings Date | 03/04/24 | 02/26/26 | 02/24/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||